仙琚制药：雌二醇片/雌二醇地屈孕酮片复合包装药品注册申请获得受理

Core Viewpoint - The company has received a drug registration acceptance notice from the National Medical Products Administration for a combined packaging of estradiol tablets and estradiol/dydrogesterone tablets, indicating a significant step towards market entry for these products [1] Group 1 - The product name is estradiol tablets/estradiol/dydrogesterone tablets combined packaging, with dosage forms including tablets [1] - Specifications include estradiol tablets containing 1mg and estradiol/dydrogesterone tablets containing 1mg of estradiol and 10mg of dydrogesterone, as well as estradiol tablets containing 2mg and estradiol/dydrogesterone tablets containing 2mg of estradiol and 10mg of dydrogesterone [1] - The application is for domestic production drug registration and marketing authorization, with acceptance numbers CYHS2504314 and CYHS2504315 [1]